Plasma free dopamine in human hypertension. 1989

Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

The concentration of plasma free dopamine (PDA) is said to be much lower than that of other catecholamines and its physiological significance remains unclear. Our recent studies using a newly developed radioenzymatic method disclosed the fairly distinctive features of PDA in patients with various types of hypertension. PDA was also confirmed as a variable responsive to postural change, dietary sodium loading and dopamine receptor antagonist. The results suggest that PDA could be a sensitive marker to represent the peripheral dopaminergic function, which might play an inherent role as a physiological regulator responsible for the cardiovascular and endocrine system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
March 1979, The Journal of clinical endocrinology and metabolism,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
January 1989, Rinsho byori. The Japanese journal of clinical pathology,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
January 1983, Acta medica Scandinavica,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
January 1981, Hypertension (Dallas, Tex. : 1979),
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
January 1984, Journal of psychiatric research,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
January 1990, Clinical physiology (Oxford, England),
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
June 1981, British journal of obstetrics and gynaecology,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
May 1975, Circulation,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
June 1973, Clinical science,
Y Miura, and M Takahashi, and N Sano, and T Ohzeki, and Y Meguro, and T Sugawara, and T Noshiro, and H Watanabe, and K Shimizu, and K Abe
September 1983, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!